Tevogen Bio Holdings Inc. (NASDAQ: TVGN) shares are trading higher Monday, potentially driven by momentum from a late-Friday ...

We recently compiled a list of the 10 AI News and Ratings Investors Should Not Miss. In this article, we are going to take a ...

In recent trading, Tevogen Bio Holdings Inc (TVGN) stock price has shown some volatility, fluctuating -32.55% over the last five trades and 438.34% over the past 30 trades. This represents a notable ...

By leveraging Microsoft's advanced tool collection, Tevogen Bio aims to establish an oncology product portfolio.

Tevogen Bio Inc. has begun preclinical efforts for TVGN-920, its first oncology product. The company is leveraging ...

Tevogen Bio (TVGN) announced its Artificial Intelligence effort, Tevogen.AI, had partnered with Microsoft (MSFT) (MSFR) Using Microsoft’s ...

Tevogen Bio begins pre-clinical effort for TVGN 920, signaling the start of its oncology treatment pipeline.Tevogen Bio created a data set containing known proteins in the HPV genome to identify ...

WARREN, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio ("Tevogen” or "Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a ...

Beam Therapeutics Inc. disclosed that one patient died in the phase I/II trial testing BEAM-101 in sickle cell disease (SCD), though the case of respiratory failure was determined by the investigator ...

Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell ...

In recent trading, Tevogen Bio Holdings Inc (TVGN) stock price has shown some volatility, fluctuating -1.17% over the last five trades and 723.30% over the past 30 trades. This represents a notable ...

WARREN, N.J. - Tevogen Bio (NASDAQ:TVGN), a clinical-stage immunotherapy biotech company, has announced a partnership with Microsoft (NASDAQ:MSFT) to utilize artificial intelligence (AI) in ...